Marc-Alexander Mahl
Member of Management BoardDr. Marc-Alexander Mahl is Member of Management Board of Fresenius SE & Co. KGaA from November 1, 2026. Dr. Mahl is Member of Management Board & President Pharma, Medical Nutrition and Sustainability of Fresenius Kabi Aktiengesellschaft. Dr. Mahl has headed Fresenius' Pharma and Nutrition businesses since May 2023. In addition, he oversees sustainability activities in these businesses. Mahl has been with Fresenius since July 2001, with a brief interruption and has since held various management positions with regional and global responsibilities. Since 2011, he has been responsible for the global Pharma business. In parallel, Mahl served as President of Medicines for Europe and as a member of the Executive Committee of the German industry association for specialized nutrition. Mahl studied medicine, is a specialist in transfusion medicine and holds an MBA from INSEAD.
Positions
- Company NameFresenius SE & Co. KGaAStock CodeFSNUYPositionMember of Management BoardColleagues
- MSMichael SenCEO, President & Chairman of Management Board of Fresenius Management SE
- WKWolfgang KirschIndependent Chairman of Supervisory Board
- SLSara Lisa HennickenCFO & Member of the Management Board - Fresenius Management SE
- MSMichael Sven MoserMember of Management Board of Fresenius Management SE
- CPChristian PawluMember of Management Board
- MDMichael DiekmannIndependent Deputy Chairman of the Supervisory Board
- GGGrit GensterIndependent Deputy Chairperson of the Supervisory Board
- GEGerd E. KrickHonorary Chairman of Supervisory Board
- SZSusanne ZeidlerIndependent Member of the Supervisory Board
